# Establish Diagnostic and Prognostic Models for Preclinical AD Patients Based on Multimodal MRI, Behavioral, Genetic, and Plasma Biomarkers

> **NCT06561906** · — · RECRUITING · sponsor: **The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School** · enrollment: 1000 (estimated)

## Conditions studied

- Alzheimer Disease, Late Onset
- Mild Cognitive Impairment
- Subjective Cognitive Decline

## Interventions

- **OTHER:** Multimodal magnetic resonance imaging scanning, behavioral, genetic and plasma biomarker testing

## Key facts

- **NCT ID:** NCT06561906
- **Lead sponsor:** The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2020-09-01
- **Primary completion:** 2027-07
- **Final completion:** 2027-12
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2024-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06561906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06561906, "Establish Diagnostic and Prognostic Models for Preclinical AD Patients Based on Multimodal MRI, Behavioral, Genetic, and Plasma Biomarkers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06561906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*